Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Pillar Invest Corp. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Pillar Invest Corp zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ACGN / Aceragen Inc | 10% Owner | 164 894 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Pillar Invest Corp. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Pillar Invest Corp ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-19 |
|
4 | ACGN |
Aceragen, Inc.
Common Stock |
S - Sale | -2 213 | 164 894 | -1,32 | 1,54 | -3 408 | 253 937 | |
| 2023-07-19 |
|
4 | ACGN |
Aceragen, Inc.
Common Stock |
S - Sale | -3 605 | 167 107 | -2,11 | 1,58 | -5 696 | 264 029 | |
| 2023-07-19 | 3/A | ACGN |
Aceragen, Inc.
Common Stock |
355 247 | ||||||||
| 2023-07-19 | 3/A | ACGN |
Aceragen, Inc.
Common Stock |
135 540 | ||||||||
| 2023-07-19 | 3/A | ACGN |
Aceragen, Inc.
Common Stock |
143 747 | ||||||||
| 2023-07-19 | 3/A | ACGN |
Aceragen, Inc.
Common Stock |
1 547 | ||||||||
| 2023-07-19 |
|
4 | ACGN |
Aceragen, Inc.
Common Stock |
P - Purchase | 26 965 | 170 712 | 18,76 | 1,42 | 38 290 | 242 411 | |
| 2023-06-23 | 3 | ACGN |
Aceragen, Inc.
Common Stock |
355 247 | ||||||||
| 2023-06-23 | 3 | ACGN |
Aceragen, Inc.
Common Stock |
135 540 | ||||||||
| 2023-06-23 | 3 | ACGN |
Aceragen, Inc.
Common Stock |
170 712 | ||||||||
| 2023-06-23 | 3 | ACGN |
Aceragen, Inc.
Common Stock |
1 547 | ||||||||
| 2022-09-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 533 159 | 7 266 954 | 26,74 | 0,01 | 15 332 | 72 670 | |
| 2021-04-29 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
X - Other | -883 613 | 883 613 | -50,00 | 0,01 | -8 836 | 8 836 | |
| 2021-04-29 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
X - Other | -1 612 196 | 1 612 196 | -50,00 | 0,01 | -16 122 | 16 122 | |
| 2021-04-29 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 883 613 | 2 304 180 | 62,20 | 0,01 | 8 836 | 23 042 | |
| 2021-04-29 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 612 196 | 5 733 795 | 39,12 | 0,01 | 16 122 | 57 338 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
X - Other | -884 175 | 884 175 | -50,00 | 0,01 | -8 842 | 8 842 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
X - Other | -1 611 634 | 1 611 634 | -50,00 | 0,01 | -16 116 | 16 116 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 884 175 | 2 492 342 | 54,98 | 0,01 | 8 842 | 24 923 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 611 634 | 5 733 233 | 39,10 | 0,01 | 16 116 | 57 332 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | 323 726 | 1 608 167 | 25,20 | 1,80 | 582 221 | 2 892 288 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | 1 376 039 | 4 121 599 | 50,12 | 1,80 | 2 474 806 | 7 412 696 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
X - Other | -643 525 | 643 525 | -50,00 | 0,01 | -6 435 | 6 435 | |
| 2021-03-31 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 643 525 | 1 931 893 | 49,95 | 0,01 | 6 435 | 19 319 | |
| 2020-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Warrants |
P - Purchase | 766 941 | 766 941 | |||||
| 2020-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Warrants |
P - Purchase | 606 885 | 606 885 | |||||
| 2020-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
P - Purchase | 1 533 883 | 1 533 883 | |||||
| 2020-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
P - Purchase | 1 143 428 | 1 143 428 | |||||
| 2020-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 69 941 | 5 497 638 | 1,29 | 1,82 | 127 293 | 10 005 701 | |
| 2020-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Warrants |
P - Purchase | 3 039 514 | 3 039 514 | |||||
| 2020-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -103 891 | 1 288 368 | -7,46 | ||||
| 2020-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -46 304 | 5 427 697 | -0,85 | ||||
| 2020-07-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Warrants |
P - Purchase | 2 764 227 | 2 764 227 | |||||
| 2020-07-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Prefunded Warrants |
P - Purchase | 2 014 234 | 2 014 234 | |||||
| 2020-07-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 749 993 | 5 427 697 | 16,03 | 1,72 | 1 289 988 | 9 335 639 | |
| 2020-04-09 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3 039 514 | 6 260 832 | 94,36 | 1,52 | 4 620 061 | 9 516 465 | |
| 2020-02-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -17 250 | 3 254 442 | -0,53 | 1,76 | -30 438 | 5 742 463 | |
| 2020-02-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -12 532 | 3 271 692 | -0,38 | 1,76 | -22 081 | 5 764 721 | |
| 2020-02-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15 000 | 3 284 224 | -0,45 | 1,77 | -26 550 | 5 813 076 | |
| 2019-11-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -9 000 | 3 299 224 | -0,27 | 2,44 | -21 960 | 8 050 107 | |
| 2019-11-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -10 000 | 3 308 224 | -0,30 | 2,45 | -24 500 | 8 105 149 | |
| 2019-11-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 000 | 3 318 224 | -2,93 | 2,50 | -249 560 | 8 280 960 | |
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2019-08-05 | 3 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
6 836 448 | ||||||||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15 000 | 0 | -100,00 | 6,35 | -95 324 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -25 000 | 0 | -100,00 | 6,29 | -157 358 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15 000 | 0 | -100,00 | 6,25 | -93 762 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -20 000 | 0 | -100,00 | 5,98 | -119 500 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -50 000 | 0 | -100,00 | 5,88 | -294 190 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8 107 | 0 | -100,00 | 5,89 | -47 759 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -75 000 | 0 | -100,00 | 5,62 | -421 718 | ||
| 2018-08-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -91 893 | 0 | -100,00 | 5,55 | -510 098 | ||
| 2018-07-24 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -492 567 | 0 | -100,00 | 0,86 | -422 672 | ||
| 2018-07-24 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -556 000 | 0 | -100,00 | 0,88 | -489 502 | ||
| 2018-07-24 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 725 000 | 0 | -100,00 | 0,85 | -1 470 390 | ||
| 2018-07-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -874 505 | 0 | -100,00 | 0,99 | -862 524 | ||
| 2018-07-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -735 771 | 0 | -100,00 | 1,01 | -743 644 | ||
| 2018-07-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -250 500 | 0 | -100,00 | 1,05 | -264 052 | ||
| 2018-04-27 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -1 200 000 | 0 | -100,00 | ||||
| 2018-04-27 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 200 000 | 0 | -100,00 | ||||
| 2018-01-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 000 | 0 | -100,00 | 2,40 | -480 000 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -33 830 | 0 | -100,00 | 1,91 | -64 527 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -700 000 | 0 | -100,00 | ||||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 000 | 0 | -100,00 | 2,00 | -599 430 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -700 000 | 0 | -100,00 | 2,00 | -1 400 000 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 700 000 | 0 | -100,00 | ||||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -166 170 | 0 | -100,00 | 2,00 | -333 171 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -600 000 | 0 | -100,00 | 1,93 | -1 158 420 | ||
| 2017-12-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -500 000 | 0 | -100,00 | 1,92 | -959 750 | ||
| 2017-10-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -6 842 844 | 0 | -100,00 | ||||
| 2017-10-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 6 842 844 | 0 | -100,00 | ||||
| 2017-05-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -409 237 | 4 624 824 | -8,13 | ||||
| 2017-05-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 409 237 | 0 | -100,00 | ||||
| 2017-05-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -409 237 | 0 | -100,00 | 2,26 | -924 507 | ||
| 2017-05-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -41 578 | 0 | -100,00 | 2,26 | -93 929 | ||
| 2017-04-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -890 593 | 0 | -100,00 | 2,29 | -2 037 944 | ||
| 2017-04-26 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -437 829 | 0 | -100,00 | 2,29 | -1 002 059 | ||
| 2016-11-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -1 370 000 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 370 000 | 0 | -100,00 | ||||
| 2015-12-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -232 759 | 5 034 061 | -4,42 | ||||
| 2015-12-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 232 759 | 0 | -100,00 | ||||
| 2015-12-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -77 587 | 0 | -100,00 | ||||
| 2015-12-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -77 586 | 0 | -100,00 | ||||
| 2015-12-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -77 586 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -2 600 000 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 2 600 000 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 000 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 000 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 000 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -359 847 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -770 155 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -676 536 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -676 535 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -25 590 | 0 | -100,00 | ||||
| 2015-12-14 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -25 591 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Series E Convertible Preferred Stock |
C - Conversion | -110 901 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -50 853 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -67 804 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -93 230 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -339 018 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -26 769 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35 692 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -49 077 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -178 462 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -24 078 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -32 104 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -44 143 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -160 521 | 0 | -100,00 | ||||
| 2014-12-16 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 2 218 020 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Series E Convertible Preferred Stock |
C - Conversion | -313 341 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 6 266 820 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -65 825 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -87 767 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -120 680 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -438 836 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -32 404 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -43 206 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -59 408 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -216 028 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -500 000 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 500 000 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -85 385 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -113 846 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -156 538 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -569 231 | 0 | -100,00 | ||||
| 2014-12-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -500 000 | 0 | -100,00 | ||||
| 2014-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -1 000 000 | 5 266 820 | -15,96 | ||||
| 2014-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 000 000 | 0 | -100,00 | ||||
| 2014-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -275 000 | 0 | -100,00 | ||||
| 2014-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 054 700 | 0 | -100,00 | ||||
| 2014-09-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -370 300 | 0 | -100,00 | ||||
| 2014-08-18 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -383 294 | 0 | -100,00 | ||||
| 2014-08-18 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -1 000 000 | 0 | -100,00 | ||||
| 2014-08-18 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 1 000 000 | 0 | -100,00 | ||||
| 2014-08-18 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -215 934 | 0 | -100,00 | ||||
| 2014-08-18 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -400 772 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -110 901 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -313 341 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
X - Other | -575 758 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 110 901 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 313 341 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
X - Other | 575 758 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -45 000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -250 000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -250 000 | 0 | -100,00 | ||||
| 2014-02-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Series D Convertible Preferred Stock |
C - Conversion | -1 124 260 | 0 | -100,00 | ||||
| 2014-02-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 6 266 175 | 6 266 175 | |||||
| 2013-10-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 032 | 0 | -100,00 | ||||
| 2013-10-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 845 161 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
P - Purchase | 2 400 000 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
P - Purchase | 2 600 000 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
A - Award | 110 901 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
A - Award | 313 341 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
A - Award | 575 758 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
A - Award | 1 000 000 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 400 000 | 0 | -100,00 | ||||
| 2013-05-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2 600 000 | 0 | -100,00 | ||||
| 2012-11-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Series E Convertible Preferred Stock |
A - Award | 424 242 | 0 | -100,00 | 14,00 | 5 939 388 | ||
| 2012-11-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants |
A - Award | 8 484 840 | 0 | -100,00 | 0,12 | 1 060 605 |